Detalles de la búsqueda
1.
Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma.
Molecules
; 29(8)2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675715
2.
Enhancing bladder cancer care through the multidisciplinary clinic approach.
Can J Urol
; 30(3): 11526-11531, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344462
3.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29129443
4.
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).
Cancer
; 122(15): 2371-8, 2016 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27163943
5.
Bladder preservation therapy for muscle-invading bladder cancers on Radiation Therapy Oncology Group trials 8802, 8903, 9506, and 9706: vascular endothelial growth factor B overexpression predicts for increased distant metastasis and shorter survival.
Oncologist
; 18(6): 685-6, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23728940
6.
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis
; 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057610
7.
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
JAMA Netw Open
; 5(11): e2242378, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36383379
8.
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
J Thorac Oncol
; 16(6): 960-967, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539971
9.
MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis.
PLoS One
; 9(9): e107677, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25232729
10.
Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitution.
J Interferon Cytokine Res
; 34(5): 376-84, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24433038
11.
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
J Clin Oncol
; 32(34): 3801-9, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25366678
12.
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.
J Clin Oncol
; 29(15): 2060-5, 2011 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21502559
13.
Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
Cancer
; 113(3): 542-6, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18512224
14.
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
J Clin Oncol
; 26(3): 468-73, 2008 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18202422
15.
Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
Cancer
; 97(8 Suppl): 2115-9, 2003 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12673704
Resultados
1 -
15
de 15
1
Próxima >
>>